Recent guidelines have restricted aspirin use in the primary prevention of cardiovascular disease. The American Heart ...
Could aspirin keep cancer from spreading? A new study from the University of Cambridge suggests that the common pain ...
Taking aspirin was first linked to a lower risk of colorectal cancer in 1988, but the research into its anti-tumour potential ...
The anti-clotting effect of aspirin may trigger a biological chain of events that stops cancer cells from metastasizing, researchers say.
Dr. Jie Yang, who carried out the researchm described the drug as a less expensive solution that is more accessible globally.
Nearly one in two respondents (48%) wrongly said that the benefits of taking low-dose aspirin daily to lower one’s odds of having a stroke or heart attack outweigh the risks, according to a ...
Studies of people with cancer have previously observed that those taking daily low-dose aspirin have a reduction in the spread of some cancers, such as breast, bowel, and prostate cancers ...
Please provide your email address to receive an email when new articles are posted on . Daily aspirin use after adjuvant therapy did not improve outcomes for patients with colorectal cancer.
Aspirin is the common name for acetylsalicylic ... Because of this it is already taken daily by more than two million angina sufferers in the UK to protect against further attacks and against ...
The findings support current guidelines recommending low-dose aspirin (81 mg) as an effective preventive measure for ...
The news is the latest in a string of discoveries about the health benefits of aspirin, which was invented more than 100 years ago. It is already taken daily by more than two million angina ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results